Cancer Research Cancer Genome no Abstract  CR Podcast
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qiuping, Z.
Right arrow Articles by Jinquan, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qiuping, Z.
Right arrow Articles by Jinquan, T.
[Cancer Research 63, 6469-6477, October 1, 2003]
© 2003 American Association for Cancer Research


Immunology

Selectively Increased Expression and Functions of Chemokine Receptor CCR9 on CD4+ T Cells from Patients with T-Cell Lineage Acute Lymphocytic Leukemia1

Zhang Qiuping2, Li Qun2, Hu Chunsong, Zhang Xiaolian, Huang Baojun, Yang Mingzhen, Lao Chengming, He Jinshen, Gao Qingping, Zhang Kejian, Sun Zhimin, Zhang Xuejun, Liu Junyan and Tan Jinquan3

Department of Immunology, Medical College [Z. Q., Z. Xi., L. J., T. J.], and Department of Hematology, The First and Second Affiliated University Hospital [G. Q., Z. K.], Wuhan University, 430071 Wuhan; Department of Immunology, College of Basic Medical Sciences, Anhui Medical University, 230032 Hefei [L. Q., H. C., H. B., L. C., H. J., Z. Xu., T. J.]; Department of Hematology, The Affiliated University Hospital, Anhui Medical University, 230031 Hefei [Y. M.]; and Department of Hematology, The Provincial Hospital of Anhui, 230020 Hefei [S. Z.], Peoples Republic of China

In a total of 38 typical T-cell lineage acute lymphocytic leukemia (T-ALL) and T-cell lineage chronic lymphocytic leukemia (T-CLL) cases investigated, we found that CC chemokine receptor CCR9 was selectively and frequently expressed on T-ALL CD4+ T cells, was moderately expressed on T-CLL CD4+ T cells, and was rarely expressed on normal CD4+ T cells. These findings were demonstrated at protein and mRNA levels using flow cytometry and real-time quantitative reverse transcription-PCR technique and were verified by digital confocal microscopy and Northern blotting. Thymus-expressed chemokine, a ligand for CCR9, selectively induced T-ALL CD4+ T-cell chemotaxis and adhesion. Interleukin (IL)-2 and IL-4, together, down-regulated the expression and functions of CCR9 in T-ALL CD4+ T cells including chemotaxis and adhesion. It was also demonstrated that IL-2 and IL-4, together, internalized CCR9 on T-ALL CD4+ T cells and subsequently inhibited functions of CCR9 in these cells. Thymus-expressed chemokine mRNA was highly expressed in CD4+ T cells, involving lymph node and skin in T-ALL patients, and was expressed at moderate levels in lymph node and skin tissues in T-CLL patients. Our findings may provide new clues to understanding various aspects of T-ALL CD4+ T cells, such as functional expression of CCR9-thymus-expressed chemokine receptor-ligand pairs as well as the effects of IL-2 and IL-4, which may be especially important in cytokine/chemokine environment for the pathophysiological events of T-ALL CD4+ T-cell trafficking.




This article has been cited by other articles:


Home page
J. Immunol.Home page
X. Wang, H. Yuling, J. Yanping, T. Xinti, Y. Yaofang, Y. Feng, X. Ruijin, W. Li, C. Lang, L. Jingyi, et al.
CCL19 and CXCL13 Synergistically Regulate Interaction between B Cell Acute Lymphocytic Leukemia CD23+CD5+ B Cells and CD8+ T Cells
J. Immunol., September 1, 2007; 179(5): 2880 - 2888.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Chunsong, H. Yuling, W. Li, X. Jie, Z. Gang, Z. Qiuping, G. Qingping, Z. Kejian, Q. Li, A. E. Chang, et al.
CXC Chemokine Ligand 13 and CC Chemokine Ligand 19 Cooperatively Render Resistance to Apoptosis in B Cell Lineage Acute and Chronic Lymphocytic Leukemia CD23+CD5+ B Cells
J. Immunol., November 15, 2006; 177(10): 6713 - 6722.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Tao, L. Shangwu, W. Qun, L. Yan, J. Wei, L. Junyan, G. Feili, J. Boquan, and T. Jinquan
CD226 Expression Deficiency Causes High Sensitivity to Apoptosis in NK T Cells from Patients with Systemic Lupus Erythematosus
J. Immunol., February 1, 2005; 174(3): 1281 - 1290.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Qiuping, X. Jei, J. Youxin, J. Wei, L. Chun, W. Jin, W. Qun, L. Yan, H. Chunsong, Y. Mingzhen, et al.
CC Chemokine Ligand 25 Enhances Resistance to Apoptosis in CD4+ T Cells from Patients with T-Cell Lineage Acute and Chronic Lymphocytic Leukemia by Means of Livin Activation
Cancer Res., October 15, 2004; 64(20): 7579 - 7587.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. E. Annels, A. J. Willemze, V. H. J. van der Velden, C. M. J. M. Faaij, E. van Wering, D. M. D. S. Sie-Go, R. M. Egeler, M. J. D. van Tol, and T. Revesz
Possible link between unique chemokine and homing receptor expression at diagnosis and relapse location in a patient with childhood T-ALL
Blood, April 1, 2004; 103(7): 2806 - 2808.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.